Overview

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study how helpful thalidomide is in controlling the disease and to study any side effects from taking thalidomide.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arkansas
Collaborator:
Celgene Corporation
Treatments:
Thalidomide